TBK1 and neoplasm: More importantly, we found the antimiRs(21+9+10b) treatment combined with the TBK1 inhibitor Amlexanox, which suppressed the formation and activity of oncogenic miRISCs, had the best anti‐tumor effect (Figure 6).